Downstream Processing of Monoclonal Antibodies: Current Practices and Future Opportunities
نویسندگان
چکیده
s of Papers, 232nd ACS Meeting, San Francisco, CA, 2006. Yigzaw, Y. , Piper, R. , Tran , M. , Shukla , A.A. ( 2006 ). Exploitation of the adsorptive properties of depth filters for host cell protein removal during monoclonal antibody purifi cation. Biotechnology Progress 22, 288–296. Roque, A.C.A. , Silva, C.S.O. , Taipa, M.A. (2007). Affi nity-based methodologies and ligands for antibody purifi cation: Advances and perspectives. Journal of Chromatography A 1160, 44–55. Zhou, J.X., Tressel, T. (2006). Basic concepts in Q membrane chromatography for large-scale antibody production . Biotechnology Progress 22, 341–349. Luan, Y.-T. (2006). Defi ned medium development for high yielding mammalian cell culture processes. BioProcess International Conference & Exhibition: IBC’s 7th International Cell Culture & Upstream Processing, San Francisco, CA, 2006. Jagschies, G., Grönberg, A., Björkman, T., Lacki, K., Johansson, H.J. (2006). Technical and economical evaluation of downstream processing options for monoclonal antibody (Mab) production. BioPharm International 19 (suppl.), 2–8. Kelley, B.D. (2007). Very large scale monoclonal antibody purification: The case for conventional unit operations. Biotechnology Progress 23, 995–1008. Hagel, L., Jagschies, G., Sofer, G. (2007). Production scenarios. In Hagel, L., Jagschies, G., Sofer, G. (eds.) Handbook of Process Chromatography: Development, Manufacturing, Validation and Economics , 2nd eds., Academic Press, London, pp.
منابع مشابه
Multimodal chromatography: debottlenecking the downstream processing of monoclonal antibodies
2015 The commercial potential of monoclonal antibodies (mAbs) has been continuously increasing during the last years alongside with the number of approved mAb-based drugs and clinical trials. Despite their effectiveness and safety, the general access to this class of biopharmaceuticals is barred by high selling prices. Downstream processing is now considered the bottleneck in the manufacturing ...
متن کاملA Single-use Strategy to Enable Manufacturing of Affordable Biologics
The current processing paradigm of large manufacturing facilities dedicated to single product production is no longer an effective approach for best manufacturing practices. Increasing competition for new indications and the launch of biosimilars for the monoclonal antibody market have put pressure on manufacturers to produce at lower cost. Single-use technologies and continuous upstream proces...
متن کاملMonoclonal Antibodies
SUMMARY Monoclonal Antibodies are identical antibodies and Can be generated in ultimated amounts by countinuos cultures of single antibody- secreting cells. These cell lines are produced by cell fusion of normal lymphocytes to cells of a myeloma tumor cell line, which confers on the antibody producing hybrid cell, immortality and the ability grow as atumor in animals. monoclonal antibodies c...
متن کاملProduction and Characterization of Murine Monoclonal Antibodies to Leishmania Gp63 Antigen
Background : Production of monoclonal antibodies to Leishmania antigens assists the identification and characterization of these organisms. Objective: Production of monoclonal antibodies against epitopes on the gp63. Methods: Two murine monoclonal antibodies to gp63 were produced and characterized. The reactions of both antibodies with soluble leishmanial antigens, purified gp63 and truncated r...
متن کاملNovel downstream processes for the purification of monoclonal antibodies based on aqueous two phase partitioning and hydrophobic interaction chromatography
Monoclonal antibodies have proven their potential as therapeutic molecules with applications as diverse as diagnosis, oncology and treatment of autoimmune diseases; the need for their supply is higher than it ever was, with the global market for monoclonal antibodies being expected to grow to nearly $58 billion in 2016. The main challenge for this growth remains the fact these products need to ...
متن کامل